SwePub
Sök i LIBRIS databas

  Utökad sökning

(L773:0036 8075 OR L773:1095 9203) lar1:(liu)
 

Sökning: (L773:0036 8075 OR L773:1095 9203) lar1:(liu) > Elevated plasma neu...

Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders

Dobson, Hannah (författare)
Royal Melbourne Hospital,Alfred Health
Al Maawali, Said (författare)
Monash University
Malpas, Charles (författare)
University of Melbourne
visa fler...
Santillo, Alexander F. (författare)
Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Lund University Bioimaging Center,Medicinska fakulteten,LU profilområde: Proaktivt åldrande,Lunds universitets profilområden,Clinical Memory Research,Lund University Research Groups,Faculty of Medicine,LU Profile Area: Proactive Ageing,Lund University Profile areas
Kang, Matthew (författare)
University of Melbourne,Royal Melbourne Hospital,Alfred Health
Todaro, Marian (författare)
Alfred Health,Royal Melbourne Hospital,University of Melbourne,Monash University
Watson, Rosie (författare)
Walter and Eliza Hall Institute of Medical Research,University of Melbourne
Yassi, Nawaf (författare)
Walter and Eliza Hall Institute of Medical Research,University of Melbourne
Blennow, Kaj, 1958 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,Pitié-Salpêtrière University Hospital,Sahlgrenska Academy,Sahlgrenska University Hospital,University of Science and Technology of China
Zetterberg, Henrik, 1973 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,University of Wisconsin-Madison,University College London,Sahlgrenska Academy,Sahlgrenska University Hospital
Foster, Emma (författare)
Alfred Health,Monash University
Neal, Andrew (författare)
Alfred Health,Monash University
Velakoulis, Dennis (författare)
University of Melbourne,Royal Melbourne Hospital
O'Brien, Terence John (författare)
Monash University,University of Melbourne
Eratne, Dhamidhu (författare)
University of Melbourne,Royal Melbourne Hospital
Kwan, Patrick (författare)
University of Melbourne,Monash University,Alfred Health
visa färre...
 (creator_code:org_t)
2024
2024
Engelska.
Ingår i: EPILEPSIA. - 0013-9580 .- 1528-1167.
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • ObjectiveResearch suggests that recurrent seizures may lead to neuronal injury. Neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAP) levels increase in cerebrospinal fluid and blood in response to neuroaxonal damage, and they have been hypothesized as potential biomarkers for epilepsy. We examined plasma NfL and GFAP levels and their diagnostic utility in differentiating patients with epilepsy from those with psychogenic nonepileptic seizures (PNES) and other nonepileptic disorders.MethodsWe recruited consecutive adults admitted for video-electroencephalographic monitoring and formal neuropsychiatric assessment. NfL and GFAP levels were quantified and compared between different patient groups and an age-matched reference cohort (n = 1926) and correlated with clinical variables in patients with epilepsy.ResultsA total of 138 patients were included, of whom 104 were diagnosed with epilepsy, 22 with PNES, and 12 with other conditions. Plasma NfL and GFAP levels were elevated in patients with epilepsy compared to PNES, adjusted for age and sex (NfL p = .04, GFAP p = .04). A high proportion of patients with epilepsy (20%) had NfL levels above the 95th age-matched percentile compared to the reference cohort (5%). NfL levels above the 95th percentile of the reference cohort had a 95% positive predictive value for epilepsy. Patients with epilepsy who had NfL levels above the 95th percentile were younger than those with lower levels (37.5 vs. 43.8 years, p = .03).SignificanceAn elevated NfL or GFAP level in an individual patient may support an underlying epilepsy diagnosis, particularly in younger adults, and cautions against a diagnosis of PNES alone. Further examination of the association between NfL and GFAP levels and specific epilepsy subtypes or seizure characteristics may provide valuable insights into disease heterogeneity and contribute to the refinement of diagnosis, understanding pathophysiological mechanisms, and formulating treatment approaches.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

biomarker
epilepsy
glial fibrillary acidic protein
neurofilament light chain
nonepileptic seizures

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

  • EPILEPSIA (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy